Clinical Trial Update: Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating a combination of an oncolytic virus and a PD-1 inhibitor in advanced pancreatic cancer, and the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Oncolytic virus therapy (Oncolytic virus therapy)
• PD-1 inhibitor

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer | Phase 2 | Status: NOT_YET_RECRUITING